首页> 外国专利> New mRNA indicative of T cell activation and functional status, useful for diagnosis and therapy e.g. of autoimmunity or transplant rejection

New mRNA indicative of T cell activation and functional status, useful for diagnosis and therapy e.g. of autoimmunity or transplant rejection

机译:指示T细胞活化和功能状态的新mRNA,可用于诊断和治疗,例如自身免疫或移植排斥反应

摘要

Messenger RNA, (mRNA), (I), for use as indicator of the activation and functional status of T cells, that have increased or reduced expression, and are present at higher or lower concentration, in activated T cells, relative to normal or resting cells, where (I) hybridizes to any of 334 sequences, reproduced, or their derivatives, complements or fragments, is new. Independent claims are also included for the following: (a) polynucleotides (II) with any of the 334 specified sequences (or their derivatives, complements or fragments that hybridize to them) for use as reagent for determining the activation or functional status of T cells; (b) polypeptides (III) derived from (II); (c) reagent for determining the activation or functional status of T cells comprising (II); (d) recombinant DNA vector molecules (IV) containing one or more (II) and transcribable in T cells; (e) antibody (Ab) specific for (III); and (f) binding molecules (IV) that react specifically with (II).
机译:信使RNA(mRNA)(I)用作T细胞活化和功能状态的指标,相对于正常细胞或正常细胞,其表达增加或降低,并以较高或较低的浓度存在于活化的T细胞中(I)与334个序列(已复制的序列)或其衍生物,补体或片段杂交的静止细胞是新的。还包括以下方面的独立权利要求:(a)具有334个指定序列中的任何一个(或与其杂交的衍生物,补体或片段)的多核苷酸(II),用作确定T细胞活化或功能状态的试剂; (b)衍生自(II)的多肽(III); (c)用于确定T细胞的活化或功能状态的试剂,其包含(II); (d)包含一个或多个(II)且可在T细胞中转录的重组DNA载体分子(IV); (e)对(III)有特异性的抗体(Ab); (f)与(II)特异性反应的结合分子(IV)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号